PetVivo (PETV) Stock Price, News & Analysis

Company Overview

PetVivo, Inc., headquartered in Ormond Beach, Florida, is a regenerative biomedical technology company specializing in veterinary applications. The company's core focus is on developing and commercializing sustained-release intra-articular therapies for animals through its proprietary RediVet injectable micro-plug system. This biodegradable polymer platform is designed to provide controlled release of therapeutic agents directly into joints, targeting osteoarthritis and related inflammatory conditions in companion and performance animals.

PetVivo’s lead product, the RediVet-40 system, has been evaluated in proof-of-concept trials involving canine patients with osteoarthritis. The platform offers potential benefits over traditional injectable treatments by extending therapeutic exposure and reducing dosing frequency. PetVivo is also exploring additional development pathways for equine and other species, leveraging its delivery technology to address unmet medical needs in veterinary orthopedics.

Founded in 2015, PetVivo has cultivated collaborations with veterinary clinics and academic research institutions across North America to advance clinical studies and support product adoption. The company maintains a portfolio of patents covering its micropellet delivery technology, underlying formulations and methods of use, underscoring its commitment to proprietary innovation in animal health and regenerative medicine.

PetVivo’s leadership team combines expertise in biomedical engineering, veterinary science and commercial product development. Through ongoing research and strategic partnerships, the company aims to expand its product pipeline and establish new channels for bringing advanced regenerative therapies to veterinary healthcare providers and their patients.

Key Stats

• Today's Range: $1.25 to $1.30
• 50-Day Range: $0.78 to $1.38
• 52-Week Range: $0.40 to $1.40
• Volume: 10,900 shs
• Average Volume: 19,095 shs
• Market Capitalization: $37.48 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

PETV Stock Analysis - Frequently Asked Questions

How have PETV shares performed this year?

PetVivo's stock was trading at $0.62 at the beginning of the year. Since then, PETV stock has increased by 106.5% and is now trading at $1.28.

How were PetVivo's earnings last quarter?

PetVivo Holdings, Inc. (NASDAQ:PETV) announced its quarterly earnings results on Thursday, June, 29th. The company reported ($0.21) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.21). The business earned $0.13 million during the quarter. PetVivo had a negative trailing twelve-month return on equity of 4,813.07% and a negative net margin of 902.82%.

How do I buy shares of PetVivo?

Shares of PETV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of PetVivo own?

Based on aggregate information from My MarketBeat watchlists, some other companies that PetVivo investors own include HubSpot (HUBS), ForgeRock (FORG), Netflix (NFLX), Sportradar Group (SRAD), Dutch Bros (BROS) and ConocoPhillips (COP).

Company Calendar

• Last Earnings: 6/29/2023
• Today: 10/10/2025
• Next Earnings (Estimated): 11/13/2025
• Fiscal Year End: 3/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Surgical & medical instruments
• Sub-Industry: Medical Equipment
• Current Symbol: NASDAQ:PETV
• CIK: 1512922
• Web: www.petvivo.com
• Phone: 952-405-6216
• Fax: N/A
• Employees: 20
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): ($0.40)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$10.95 million
• Net Margins: -902.82%
• Pretax Margin: N/A
• Return on Equity: -4,813.07%
• Return on Assets: -281.78%

Debt

• Debt-to-Equity Ratio: 0.02
• Current Ratio: 0.42
• Quick Ratio: 0.47

Sales & Book Value

• Annual Sales: $1.05 million
• Price / Sales: 35.83
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($0.03) per share
• Price / Book: -42.67

Miscellaneous

• Outstanding Shares: 29,285,000
• Free Float: 19,057,000
• Market Cap: $37.48 million
• Optionable: Not Optionable
• Beta: 0.93